Dermatitis
📧 Sign up to get email alerts when something new happens for Dermatitis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-17EMA Authorised: Anzupgo (Delgocitinib) — LEO Pharma A/S
Anzupgo (delgocitinib) has been authorised by the EMA for dermatitis/eczema with LEO Pharma A/S as the marketing authorization holder.
-
CLINICAL_TRIALS trial_result · 2026-06-16Clinical Trial Results: Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. [Phase 2]
Phase 2 long-term study of GSK1070806 in atopic dermatitis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Safety and Efficacy of Tripalmitoleoylglycerol in the Treatment of Dermatitis [NA]
A completed clinical trial evaluated the safety and efficacy of tripalmitoleoylglycerol for dermatitis, using skin barrier measures and derm…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects [Phase 1]
Phase I study to evaluate safety and pharmacokinetics of a single subcutaneous dose of SHR-1894 in healthy subjects; recruitment is ongoing.
-
FDA label_change · 2026-03-16FDA Approved: DESOXIMETASONE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for desoximetasone (Saptalis Pharmaceuticals, LLC.), resulting in updated labeling for this topical …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2026-03-02Clinical Trial Update: Care Bundle for Prevention of Skin Complications and Edema in Restrained Patients [NA]
A clinical trial update notes a care bundle aimed at preventing skin complications and edema in patients subjected to physical restraints; t…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care
A completed clinical trial explores using artificial intelligence to help doctors identify skin conditions, including dermatitis and melanom…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis
Multicentre real-life data collection study assessing CareMin650™ for prevention and treatment of oral mucositis and dermatitis induced by r…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations
A completed non-interventional clinical study evaluated Ectoin Ear Spray for outer ear canal irritations, including pruritus, dermatitis, an…
-
FDA approval · 2025-12-16FDA Approved: BECLOMETHASONE DIPROPIONATE — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's Beclomethasone Dipropionate as an original-application generic medication, a topical cortic…
-
EMA approval · 2025-12-09EMA Authorised: Anzupgo (Delgocitinib) — LEO Pharma A/S
The European Medicines Agency authorised Anzupgo (delgocitinib) by LEO Pharma A/S for dermatitis and eczema in the EU.
-
FDA approval · 2025-11-10FDA Approved: CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved a generic topical product containing ciprofloxacin hydrochloride and hydrocortisone under an original application for Cosette P…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: JAK Inhibitors for Solid Malignant Tumor Patients With Immune Checkpoint Inhibitors-related Dermatitis: A Open-lable, Single Arm, Phase IIa Trial [Phase 2]
An open-label, single-arm Phase IIa trial evaluating JAK inhibitors for immune checkpoint inhibitor-related dermatitis in patients with soli…
-
FDA approval · 2025-09-16FDA Approved: FLUOCINOLONE ACETONIDE OIL — Supplemental Application (RISING PHARMA HOLDINGS, INC.)
FDA approved a supplemental application to add Fluocinolone Acetonide Oil as an approved topical formulation of fluocinolone acetonide by Ri…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in Canada
A clinical trial update assessing the burden of recreational water illness from cyanobacteria and their toxins at freshwater beaches in Cana…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: PMCF Investigation of Medical Device ChitoCare® Medical
A post-market clinical follow-up study for the ChitoCare Medical device is currently recruiting, evaluating its use for dermatitis, acne, po…
-
FDA approval · 2025-07-18FDA Approved: FLUOCINOLONE ACETONIDE OIL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Fluocinonide Acetonide Oil, a topical corticosteroid product from Rising Pharma Holdings, In…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Aquacel Hypersensitivity Dressing in TJAs [Phase 4]
Phase 4 clinical trial evaluating Aquacel Hypersensitivity Dressing in total joint arthroplasty has completed, focusing on allergic skin rea…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis. [NA]
Completed clinical trial evaluating the efficacy and tolerability of a topical MD based on SHBF for radiodermatitis; results have been poste…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Effects of Ultraviolet B Exposure Using a Ultraviolet Skin Care Device on Vitamin D Production and Immune Response in Healthy Adults [NA]
This completed clinical trial evaluated the effects of ultraviolet B exposure from a UV skin care device on vitamin D production and immune …
-
FDA approval · 2025-04-11FDA Approved: TRIAMCINOLONE ACETONIDE — Original Application (Dr. Reddy's Laboratories Inc)
The FDA approved Dr. Reddy's Laboratories' Triamcinolone Acetonide as an original application (generic) for topical use, adding a generic co…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam [NA]
A completed clinical trial evaluating the efficacy and safety of Relizema Ecofoam for dermatitis, with results posted.
-
FDA approval · 2025-02-26FDA Approved: FLUOCINONIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved fluocinonide from Quagen Pharmaceuticals LLC under an Original Application (ANDA 216389). This is a generic topical corticoster…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Impact of Combining Incontinence-associated Dermatitis Prevention and Management Course and Directive Wheel Chart [NA]
This is a completed clinical trial update assessing the impact of combining an incontinence-associated dermatitis prevention and management …
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Clinical Investigation on the Performance and Safety of DermoRelizema Ecofoam [NA]
Completed clinical investigation evaluating the performance and safety of DermoRelizema Ecofoam for dermatitis with results posted.